SCHEME 1a
SCHEME 2a
a
Reagents: (a) (CO)2Cl2, CH2Cl2; (b) SnCl4, CH2Cl2 (70%, 2
steps); (c) 5 equiv of SnCl2, EtOH, reflux (>97%).
aniline product under tin catalysis, perhaps in the form
of a tin amidate, could account for the product. The
intermediacy of aniline 4 in this process is supported by
reduction of 2b using FeSO4‚7H2O in refluxing MeOH/
H2O.19 This reaction provided the aniline derivative (4)
in excellent yield as the sole product. Exposure of 4 to
SnCl2 in hot ethanol produces 3 in 92% yield.
a
Reagents: (a) 5 equiv of SnCl2, EtOH, reflux, 2 h; (b) 10 equiv
of FeSO4‚7H2O, MeOH/H2O, reflux, 1.5 h.
produce the corresponding aniline as expected. Instead,
cyclic amidine 3 was isolated in nearly quantitative yield
(Scheme 1).16
Treatment of benzothiazepinone 1b with SnCl2 pro-
duced only a very poorly soluble solid, which could not
be characterized. This reaction was not pursued further.
A Novel Sem ip in a col Rea r r a n gem en t a n d Re-
la ted N,O-Aceta l F or m a tion . To explore this unex-
pected chemistry further we prepared the thiochro-
manone analogue of 2 (i.e., 6) using the general procedure
of Ponticello (Scheme 2).20
Treatment of 6 with SnCl2 in refluxing ethanol repro-
ducibly gave a single product in nearly quantitative yield.
However, the product was not an aniline or an amidine,
as expected from the results obtained from 2b. NMR
spectral data show incorporation of an ethoxy group and
the presence of an ester carbonyl and an exchangeable
hydrogen. An apparent triplet at δ 4.57 is attributed to
the proton attached to a methine carbon adjacent to
the sulfur atom. This triplet signal is coupled to non-
equivalent hydrogen atoms on an adjacent methylene
group (δ 2.77 and 2.70). Further NMR analysis (1H-1H
COSY, 1H-13C COSY, DEPT, and HMBC) as well as
interpretation of the IR and LRMS suggests the product
is 7.
Formation of amidines by reaction of amines and
amides with prior amide activation by electrophilic
reagents is a very common synthetic protocol,17 but
formation from nitroarene reduction or from reaction of
an amide and an amine in the presence of SnCl2 is
novel.18 No reaction takes place in the absence of SnCl2.
In this case amidine formation from the intermediate
(11) Additional structural confirmation was obtained from the 13C
chemical shifts of methine and methylene carbon atoms in seven- and
six-membered ring compounds 1a , 1b, 2a , 2b, and 4. Seven-membered
ring compounds show a CH peak at δ 45-46 and a CH2 peak at δ
39-40 [1H-13C COSY correlation to methine and methylene protons
at δ 5.51 and δ 2.84-2.98, respectively, in 1a ]. Six-membered-ring
compounds show a CH peak at δ 42-43 and a CH2 peak at δ 31-33
[1H-13C COSY correlation to methine and methylene protons at δ 3.71
and δ 2.70/3.20 (AB quartet), respectively, in 4]. These 13C chemical
shifts are in accord with the assignment of seven- and six-membered-
ring skeletons to 1 and 2, respectively.
(12) There is only one report of 1a in the literature (ref 10) and no
reports of 2a . The benzothiazepinone skeleton is generally prepared
by reacting o-aminobenzenethiol with an R,â-unsaturated carboxylic
acid (e.g., cinnamic acid) at high temperature (160-180 °C) for several
hours10,12a while the benzothiazinone skeleton is generally prepared
from an R-bromoacid (e.g., 2-bromo-3-phenylpropanoic acid).12b,c As a
product of initial direct Michael addition, 1 is expected to be the kinetic
product. However, after 1 has formed and under conditions allowing
equilibration through retro-Michael addition, even though anti-Michael
addition product 2 is disfavored kinetically it could begin to appear in
the reaction mixture since it may be favored thermodynamically. This
analysis is consistent with the 1a :2a ratio observed in our reactions.
Also, the rate of anti-Michael addition is enhanced with Michael
(16) Confirmation of structure 3 by X-ray diffraction will be reported
separately. The only impurity isolated (in very small quantity) is i,
acceptors containing
a â-group capable of stabilizing a negative
charge.12d,e All of this may mean that some compounds assigned the
benzothiazepinone skeleton in the literature may in fact be the
corresponding benzothiazinone analogue (especially when the phenyl
ring is replaced by 2-nitrophenyl, a pyridine ring or other π-deficient
heteroaromatic moieties). This is an important point because many of
the reports of applications of these reactions discuss the products as
potential therapeutic targets.10,12c,13 (a) Mills, W. H.; Whitworth, J . B.
J . Chem. Soc. 1927, 2738-2753. (b) Unger, R.; Graf, G. Chem. Ber.
1897, 30, 2387. (c) Trapani, G.; Latrofa, A.; Franco, M.; Liso, G.
Farmaco 1995, 50, 107-112. (d) Martin, V.; Molines, H.; Wakselman,
C. J . Org. Chem. 1992, 57, 5530-5532. (e) Klumpp, G. W.; Mierop, A.
J .; Vrielink, J . J .; Brugman, A.; Schakel, M. J . Am. Chem. Soc. 1985,
107, 6740-6742.
perhaps formed from an acid- or tin-catalyzed attack of ethanol on the
intermediate hydroxylamine (with loss of water) followed by amidine
formation from the derived aniline derivative. For physical and spectral
properties of i see the Experimental Section.
(17) (a) Via imidoyl triflates: Charette, A. B.; M. Grenon Tetrahe-
dron Lett. 2000, 41, 1677-1680. (b) Via imidoyl chlorides: Kraft. A.
J . Chem. Soc., Perkin Trans. 1 1999, 705-714. Benincori, T.; Sannicolo,
F. J . Heterocycl. Chem. 1988, 25, 1029-1033. (c) Via imidoesters:
Roger, R.; Neilson, D. G. In The Chemistry of Imidates; Patai, S., Ed.;
Wiley: New York, 1960; p 179.
(18) Amidine formation in a one-pot reductive cyclization of ni-
troarenes containing a cyano group is known: see refs 4c and 8.
Amidines from addition of amines to nitriles are well-known: Ogonor,
J . I. Tetrahedron 1981, 37, 2909-2910.
(13) (a)Bartch, H.; Erker, T. J . Heterocyl. Chem. 1988, 25, 1151-
1154. (b) Kori, M.; Itoh, K.; Sugihara, H. Chem. Pharm. Bull. J pn.
1987, 35, 2319-2324. (c) Slade, J .; Stanton, J . L.; Ben-David, D.;
Mazzenga, G. C. J . Med. Chem. 1985, 28, 1517-1521. (d) Carr, J . B.
J . Heterocycl. Chem. 1971, 8, 511-516. (e) Krapcho, J .; Turk, C. F. J .
Med. Chem. 1966, 9, 191-195. (f) Krapcho, J .; Spitzmiller, E. R.; Turk,
C. F. J . Med. Chem. 1963, 6, 544-546. (g) Kirchner, F. K.; Alexander,
E. J . J . Am. Chem. Soc. 1959, 81, 1721-1726.
(19) Kugita, H.; Inoue, H.; Ikezaki, M.; Takeo, S. Chem. Pharm. Bull.
1970, 18, 2028-2037.
(20) Ponticello, S. P.; Freedman, M. B.; Habecker, C. N.; Holloway,
M. K.; Amato, J . S.; Conn, R. S.; Baldwin, J . J . J . Org. Chem. 1988,
53, 9-13.
(14) Gaino, M.; Iijima, I.; Nishimoto, S.; Ikeda, K.; Fujii, T. J pn.
Kakai 1983, 58-99471; Chem. Abstr. 1983, 99, 175819v.
(15) Bellamy, F. D.; Ou, K. Tetrahedron Lett. 1984, 25, 839-842.
J . Org. Chem, Vol. 67, No. 24, 2002 8663